Announcements Trials
Browse Landscape

Phase

Phase NA 33Phase 2 23Phase 1 16Phase EARLY_PHASE1 12Phase 2/3 5Phase 1/2 4Phase 4 2Phase 3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Genitourinary 1Endocrine 1

Conditions

Prostatic Neoplasms 1Neuroendocrine Tumors 1Disease 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Positron Emission Tomography Computed Tomography × Clear all
NCT06479187 2025-11-05

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Brigham and Women's Hospital

Phase 4 Active not recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT02621541 2016-01-06

Nonfunctional Pancreatic NET and PET Imaging

Turku University Hospital

Phase 4 Unknown
20 enrolled
EndocrineNET

Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡